147 related articles for article (PubMed ID: 32940694)
1. Electronic health records contain dispersed risk factor information that could be used to prevent breast and ovarian cancer.
Payne TH; Zhao LP; Le C; Wilcox P; Yi T; Hinshaw J; Hussey D; Kostrinsky-Thomas A; Hale M; Brimm J; Hisama FM
J Am Med Inform Assoc; 2020 Jul; 27(9):1443-1449. PubMed ID: 32940694
[TBL] [Abstract][Full Text] [Related]
2. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A
Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682
[TBL] [Abstract][Full Text] [Related]
3. Value of a genetics clinic evaluation in identifying women at risk for hereditary breast-ovarian cancer syndrome.
Hinshaw JC; Zhao LP; Brimm JE; Payne TH; Hisama FM
J Genet Couns; 2021 Dec; 30(6):1591-1597. PubMed ID: 33881185
[TBL] [Abstract][Full Text] [Related]
4. Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?
Aitken L; Warwick L; Davis A
Intern Med J; 2017 Mar; 47(3):311-317. PubMed ID: 28019080
[TBL] [Abstract][Full Text] [Related]
5. Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.
Stuckey A; Febbraro T; Laprise J; Wilbur JS; Lopes V; Robison K
Am J Clin Oncol; 2016 Aug; 39(4):363-7. PubMed ID: 24710121
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of National Comprehensive Cancer Network guideline-based Tool for Risk Assessment for breast and ovarian Cancer (N-TRAC): A patient-reported survey for genetic high-risk assessment for breast and ovarian cancers in women.
Ozanne EM; Howe R; Mallinson D; Esserman L; Van't Veer LJ; Kaplan CP
J Genet Couns; 2019 Jun; 28(3):507-515. PubMed ID: 30663827
[TBL] [Abstract][Full Text] [Related]
7. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A
Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368
[TBL] [Abstract][Full Text] [Related]
8. Improving referral for genetic risk assessment in ovarian cancer using an electronic medical record system.
Petzel SV; Vogel RI; McNiel J; Leininger A; Argenta PA; Geller MA
Int J Gynecol Cancer; 2014 Jul; 24(6):1003-9. PubMed ID: 24887442
[TBL] [Abstract][Full Text] [Related]
9. Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices.
Symecko H; Schnoll R; Beidas RS; Bekelman JE; Blumenthal D; Bauer AM; Gabriel P; Boisseau L; Doucette A; Powers J; Cappadocia J; McKenna DB; Richardville R; Cuff L; Offer R; Clement EG; Buttenheim AM; Asch DA; Rendle KA; Shelton RC; Fayanju OM; Wileyto EP; Plag M; Ware S; Shulman LN; Nathanson KL; Domchek SM
Implement Sci; 2023 Nov; 18(1):57. PubMed ID: 37932730
[TBL] [Abstract][Full Text] [Related]
10. A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer risk.
Vogel TJ; Stoops K; Bennett RL; Miller M; Swisher EM
Gynecol Oncol; 2012 Jun; 125(3):693-8. PubMed ID: 22446623
[TBL] [Abstract][Full Text] [Related]
11. Breast & ovarian cancer. Issues in risk assessment.
Caro SW
Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
[No Abstract] [Full Text] [Related]
12. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
[TBL] [Abstract][Full Text] [Related]
13. Changing patterns of referrals and outcomes of genetic participation in gynaecological-oncology multidisciplinary care.
Pokharel HP; Hacker NF; Andrews L
Aust N Z J Obstet Gynaecol; 2016 Dec; 56(6):633-638. PubMed ID: 27530527
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
Uyar D; Neary J; Monroe A; Nugent M; Simpson P; Geurts JL
Gynecol Oncol; 2018 Jun; 149(3):565-569. PubMed ID: 29653687
[TBL] [Abstract][Full Text] [Related]
15. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Daly MB; Pilarski R; Axilbund JE; Berry M; Buys SS; Crawford B; Farmer M; Friedman S; Garber JE; Khan S; Klein C; Kohlmann W; Kurian A; Litton JK; Madlensky L; Marcom PK; Merajver SD; Offit K; Pal T; Rana H; Reiser G; Robson ME; Shannon KM; Swisher E; Voian NC; Weitzel JN; Whelan A; Wick MJ; Wiesner GL; Dwyer M; Kumar R; Darlow S
J Natl Compr Canc Netw; 2016 Feb; 14(2):153-62. PubMed ID: 26850485
[TBL] [Abstract][Full Text] [Related]
16. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.
Nelson HD; Huffman LH; Fu R; Harris EL;
Ann Intern Med; 2005 Sep; 143(5):362-79. PubMed ID: 16144895
[TBL] [Abstract][Full Text] [Related]
17. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada.
Raphael J; Verma S; Hewitt P; Eisen A
J Genet Couns; 2016 Dec; 25(6):1309-1316. PubMed ID: 27228984
[TBL] [Abstract][Full Text] [Related]
20. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
